Home/Filings/4/0000899243-18-019325
4//SEC Filing

MRL Ventures Fund LLC 4

Accession 0000899243-18-019325

CIK 0001693415other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:44 PM ET

Size

11.0 KB

Accession

0000899243-18-019325

Insider Transaction Report

Form 4
Period: 2018-07-02
Transactions
  • Conversion

    Common Stock

    2018-07-02+1,848,5031,848,503 total
  • Conversion

    Series C Preferred Stock

    2018-07-021,010,1010 total
    Common Stock (181,819 underlying)
  • Purchase

    Common Stock

    2018-07-02$13.00/sh+25,000$325,0001,873,503 total
  • Conversion

    Series B Preferred Stock

    2018-07-029,259,2590 total
    Common Stock (1,666,683 underlying)
Footnotes (1)
  • [F1]The Series B and Series C Preferred Stock converted into Common Stock on a 5.5555-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.

Issuer

Translate Bio, Inc.

CIK 0001693415

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001742519

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:44 PM ET
Size
11.0 KB